Ryan Specialty (NYSE: RYAN), a leading international specialty insurance intermediary, is pleased to announce the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting ...
The expansion builds on Sproutr's established reputation for comprehensive program development, which includes underwriting and program design, product development and regulatory execution, and ...
Patra, a leading provider of AI-powered software solutions and technology-enabled insurance outsourcing services, today released its 2026 AI and Insurtech Trends: P&C Distribution Channels report. The ...
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...
GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...
MGUS is a condition where the bone marrow produces an abnormal amount of a single type of antibody called a monoclonal protein. Image credit: Billion Photos via Shutterstock. · Medical Device Network ...
Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people with MGUS (monoclonal gammopathy of unknown significance), a precursor to ...
COVID-19 infection may lead to autoimmunity by mimicking self-antigens and interfering with immune tolerance. A rare case has been reported of a patient with monoclonal gammopathy of undetermined ...
Ascot Group is a global specialty insurance and reinsurance group with a record of underwriting excellence and superior claims service. Founded in 2001, Ascot provides a broad range of customized ...
Bermudian-based Ascot Group Ltd has agreed to sell the Property and Casualty managing general underwriters owned by Ethos Specialty Insurance LLC to Ryan Specialty, the international specialty ...
BIRMINGHAM, England--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been 510k cleared, following US Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results